Edyta Maria Urbanska

Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report

Henrik Holten‐Rossing, Morten Grauslund, Edyta Maria Urbanska et al. · BMC Research Notes · 2013 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition

Edyta Maria Urbanska, Jens Benn Sørensen, Linea Cecilie Melchior et al. · International Journal of Molecular Sciences · 2020 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3 -mutation, localized transformation to EGFR -mutated SCLC, and acquired T790M EGFR -mutation

Eric Santoni‐Rugiu, Morten Grauslund, Linea Cecilie Melchior et al. · Lung Cancer · 2017 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic<i>ANK3-RET</i>Fusion in<i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer

Edyta Maria Urbanska, Jens Benn Sørensen, Linea Cecilie Melchior et al. · JCO Precision Oncology · 2022 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

Edyta Maria Urbanska, Eric Santoni‐Rugiu, Linea Cecilie Melchior et al. · Clinical Lung Cancer · 2020 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17